Tacrolimus exposure in the real world: An analysis from the Mycophenolic acid Observational REnal transplant study

Fuad S. Shihab, Ali Olyaei, Anne Wiland, Kevin Mccague, Douglas Norman

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Tacrolimus exposure and renal function data to 36 months post-transplant were analyzed from the prospective, observational Mycophenolic acid Observational REnal transplant (MORE) registry in which de novo kidney transplant patients were managed according to local practice. Tacrolimus trough (C0) concentration at month 12 was stratified as low (8 ng/mL) in 724 patients. Estimated glomerular filtration rate (eGFR) was stratified as low (2) or high (≥60 mL/min/1.73 m2). High tacrolimus C0 (>8 ng/mL) was observed in 47.7%, 34.1%, 26.8%, and 26.7% of patients at baseline and months 12, 24, and 36, respectively. Biopsy-proven acute rejection was similar to month 36 regardless of tacrolimus C0 category at month 12. Tacrolimus C0 >8 ng/mL vs. 0 cohort. Neutropenia was most frequent in the high tacrolimus C0 category (p = 0.010). In conclusion, over a quarter of patients were exposed to high tacrolimus C0 to 36 months post-transplant. Tacrolimus exposure did not affect rejection risk, but tacrolimus C0 >8 ng/mL at month 12 was predictive of subsequent low eGFR compared to C0

Original languageEnglish (US)
Pages (from-to)768-775
Number of pages8
JournalClinical Transplantation
Volume28
Issue number7
DOIs
StatePublished - 2014

Fingerprint

Mycophenolic Acid
Tacrolimus
Transplants
Kidney
Glomerular Filtration Rate
Neutropenia
Registries
Biopsy

Keywords

  • Clinical
  • Dose
  • Evolution
  • Exposure
  • Kidney transplantation
  • Mycophenolic acid Observational REnal transplant
  • Reduction
  • Tacrolimus

ASJC Scopus subject areas

  • Transplantation
  • Medicine(all)

Cite this

Tacrolimus exposure in the real world : An analysis from the Mycophenolic acid Observational REnal transplant study. / Shihab, Fuad S.; Olyaei, Ali; Wiland, Anne; Mccague, Kevin; Norman, Douglas.

In: Clinical Transplantation, Vol. 28, No. 7, 2014, p. 768-775.

Research output: Contribution to journalArticle

Shihab, Fuad S. ; Olyaei, Ali ; Wiland, Anne ; Mccague, Kevin ; Norman, Douglas. / Tacrolimus exposure in the real world : An analysis from the Mycophenolic acid Observational REnal transplant study. In: Clinical Transplantation. 2014 ; Vol. 28, No. 7. pp. 768-775.
@article{34c020738aad40e3986fc8301179e9a4,
title = "Tacrolimus exposure in the real world: An analysis from the Mycophenolic acid Observational REnal transplant study",
abstract = "Tacrolimus exposure and renal function data to 36 months post-transplant were analyzed from the prospective, observational Mycophenolic acid Observational REnal transplant (MORE) registry in which de novo kidney transplant patients were managed according to local practice. Tacrolimus trough (C0) concentration at month 12 was stratified as low (8 ng/mL) in 724 patients. Estimated glomerular filtration rate (eGFR) was stratified as low (2) or high (≥60 mL/min/1.73 m2). High tacrolimus C0 (>8 ng/mL) was observed in 47.7{\%}, 34.1{\%}, 26.8{\%}, and 26.7{\%} of patients at baseline and months 12, 24, and 36, respectively. Biopsy-proven acute rejection was similar to month 36 regardless of tacrolimus C0 category at month 12. Tacrolimus C0 >8 ng/mL vs. 0 cohort. Neutropenia was most frequent in the high tacrolimus C0 category (p = 0.010). In conclusion, over a quarter of patients were exposed to high tacrolimus C0 to 36 months post-transplant. Tacrolimus exposure did not affect rejection risk, but tacrolimus C0 >8 ng/mL at month 12 was predictive of subsequent low eGFR compared to C0",
keywords = "Clinical, Dose, Evolution, Exposure, Kidney transplantation, Mycophenolic acid Observational REnal transplant, Reduction, Tacrolimus",
author = "Shihab, {Fuad S.} and Ali Olyaei and Anne Wiland and Kevin Mccague and Douglas Norman",
year = "2014",
doi = "10.1111/ctr.12377",
language = "English (US)",
volume = "28",
pages = "768--775",
journal = "Clinical Transplantation",
issn = "0902-0063",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Tacrolimus exposure in the real world

T2 - An analysis from the Mycophenolic acid Observational REnal transplant study

AU - Shihab, Fuad S.

AU - Olyaei, Ali

AU - Wiland, Anne

AU - Mccague, Kevin

AU - Norman, Douglas

PY - 2014

Y1 - 2014

N2 - Tacrolimus exposure and renal function data to 36 months post-transplant were analyzed from the prospective, observational Mycophenolic acid Observational REnal transplant (MORE) registry in which de novo kidney transplant patients were managed according to local practice. Tacrolimus trough (C0) concentration at month 12 was stratified as low (8 ng/mL) in 724 patients. Estimated glomerular filtration rate (eGFR) was stratified as low (2) or high (≥60 mL/min/1.73 m2). High tacrolimus C0 (>8 ng/mL) was observed in 47.7%, 34.1%, 26.8%, and 26.7% of patients at baseline and months 12, 24, and 36, respectively. Biopsy-proven acute rejection was similar to month 36 regardless of tacrolimus C0 category at month 12. Tacrolimus C0 >8 ng/mL vs. 0 cohort. Neutropenia was most frequent in the high tacrolimus C0 category (p = 0.010). In conclusion, over a quarter of patients were exposed to high tacrolimus C0 to 36 months post-transplant. Tacrolimus exposure did not affect rejection risk, but tacrolimus C0 >8 ng/mL at month 12 was predictive of subsequent low eGFR compared to C0

AB - Tacrolimus exposure and renal function data to 36 months post-transplant were analyzed from the prospective, observational Mycophenolic acid Observational REnal transplant (MORE) registry in which de novo kidney transplant patients were managed according to local practice. Tacrolimus trough (C0) concentration at month 12 was stratified as low (8 ng/mL) in 724 patients. Estimated glomerular filtration rate (eGFR) was stratified as low (2) or high (≥60 mL/min/1.73 m2). High tacrolimus C0 (>8 ng/mL) was observed in 47.7%, 34.1%, 26.8%, and 26.7% of patients at baseline and months 12, 24, and 36, respectively. Biopsy-proven acute rejection was similar to month 36 regardless of tacrolimus C0 category at month 12. Tacrolimus C0 >8 ng/mL vs. 0 cohort. Neutropenia was most frequent in the high tacrolimus C0 category (p = 0.010). In conclusion, over a quarter of patients were exposed to high tacrolimus C0 to 36 months post-transplant. Tacrolimus exposure did not affect rejection risk, but tacrolimus C0 >8 ng/mL at month 12 was predictive of subsequent low eGFR compared to C0

KW - Clinical

KW - Dose

KW - Evolution

KW - Exposure

KW - Kidney transplantation

KW - Mycophenolic acid Observational REnal transplant

KW - Reduction

KW - Tacrolimus

UR - http://www.scopus.com/inward/record.url?scp=84903755375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903755375&partnerID=8YFLogxK

U2 - 10.1111/ctr.12377

DO - 10.1111/ctr.12377

M3 - Article

C2 - 24754603

AN - SCOPUS:84903755375

VL - 28

SP - 768

EP - 775

JO - Clinical Transplantation

JF - Clinical Transplantation

SN - 0902-0063

IS - 7

ER -